Most sold healthcare stocks in Q3 2017

See which Healthcare stocks institutional investors trimmed or exited the most in Q3 2017, measured as net reductions in reported share positions from Q2 2017 into Q3 2017. Notable reductions at the top of this list include ZOETIS INC (ZTS), NOVARTIS AG-SPONSORED ADR (NVS), WALGREENS BOOTS ALLIANCE INC (WBA), ABBOTT LABORATORIES (ABT). These rankings are based on SEC 13F filings from the investors we track.

SymbolNameNet sharesNet valueNewAddedTrimmedSold outHolding now
ZTSZOETIS INC-4,304,813-$259.83K00213
NVSNOVARTIS AG-SPONSORED ADR-4,101,379-$152.61K12509
WBAWALGREENS BOOTS ALLIANCE INC-3,582,788-$286.33K12217
ABTABBOTT LABORATORIES-3,331,600-$139.41K02325
DHRDANAHER CORP-2,968,361-$220.03K02509
BKDBROOKDALE SENIOR LIVING INC-2,358,324-$34.69K00020
TDOCTELADOC HEALTH INC-2,289,346-$82.23K10102
JNJJOHNSON & JOHNSON-2,286,991-$357.62K047115
BAXBAXTER INTERNATIONAL INC-1,915,957-$14.66K00508
ABBVABBVIE INC-1,875,189-$107.38K03519
BSXBOSTON SCIENTIFIC CORP-1,827,134-$41.85K01203
HALOHALOZYME THERAPEUTICS INC-1,728,876$8.07K01203
UHSUNIVERSAL HEALTH SERVICES-B-1,053,508-$142.54K01112
EXASEXACT SCIENCES CORP-792,211-$27.83K00101
BIIBBIOGEN INC-641,632-$167.29K02205
IRWDIRONWOOD PHARMACEUTICALS INC-630,253-$11.90K00010
HCAHCA HEALTHCARE INC-626,700-$56.05K01011
PHGKONINKLIJKE PHILIPS NVR- NY-615,392-$20.40K00202
AZNASTRAZENECA PLC-SPONS ADR-599,971-$32.26K00111
SNYSANOFI-ADR-597,335$96.56K00206
OPKOPKO HEALTH INC-538,200-$3.24K00101
DVADAVITA INC-536,698-$241.91K00022
CYHCOMMUNITY HEALTH SYSTEMS INC-473,273-$4.83K01011
OMIOWENS & MINOR INC-466,844-$19.94K01102
OSURORASURE TECHNOLOGIES INC-421,200$17.27K00101
BMYBRISTOL-MYERS SQUIBB CO-415,542$446.63K216010
GRFSGRIFOLS SA-ADR-411,434$9.99K01102
ARWRARROWHEAD PHARMACEUTICALS IN-374,164-$60600010
CNCCENTENE CORP-365,833-$4.14K01102
ZBHZIMMER BIOMET HOLDINGS INC-362,693-$73.80K02217
PBHPRESTIGE CONSUMER HEALTHCARE-353,260-$19.23K01102
CPRXCATALYST PHARMACEUTICALS INC-310,200-$99500101
MMSIMERIT MEDICAL SYSTEMS INC-296,800-$10.74K00101
PFEPFIZER INC-288,974$535.54K046012
THCTENET HEALTHCARE CORP-280,042-$6.87K10011
RDYDR. REDDY'S LABORATORIES-ADR-275,400-$12.88K00202
ANGOANGIODYNAMICS INC-214,210-$3.07K00101
GLPGGALAPAGOS NV-SPON ADR-198,800-$8.49K00101
ARAYACCURAY INC-184,500-$4.03K00101
BCRXBIOCRYST PHARMACEUTICALS INC-178,000-$1.06K00101
SENSSENSEONICS HOLDINGS INC-176,877-$26900111
PODDINSULET CORP-173,800-$8.34K00101
CUTRCUTERA INC-168,820$11.78K00101
CRLCHARLES RIVER LABORATORIES-167,498$4.22K01203
HUMHUMANA INC-166,907-$29.14K01021
ICUIICU MEDICAL INC-145,300-$19.15K00101
RGENREPLIGEN CORP-139,900-$6.29K00101
GKOSGLAUKOS CORP-137,100-$9.95K00101
TCMDTACTILE SYSTEMS TECHNOLOGY I-127,300-$3.47K00101
ELVELEVANCE HEALTH INC-126,688-$8.55K03409
20 symbols with net change in reported shares from tracked managers.−4.7M−3.6M−2.4M−1.2M0.00Net change in reported shares (tracked managers)ZTSNVSWBAABTDHRBKDTDOCJNJBAXABBVBSXHALOUHSEXASBIIBIRWDHCAPHGAZNSNYSymbol

Frequently asked questions about Most sold healthcare stocks in Q3 2017

  • What are the most sold Healthcare stocks in Q3 2017?

    The most sold healthcare stocks in Q3 2017 are those with the largest decrease in reported share counts across tracked institutional investors compared to Q2 2017, based on SEC 13F filings.

  • Which healthcare stocks did institutional investors trimmed or exited the most in Q3 2017?

    Among the managers we track, net reductions were largest in companies such as ZOETIS INC (ZTS), NOVARTIS AG-SPONSORED ADR (NVS), WALGREENS BOOTS ALLIANCE INC (WBA), based on aggregated 13F data.

  • How is institutional selling calculated?

    Selling is calculated by summing the net decrease in shares reported by tracked investors between two consecutive quarterly 13F snapshots (compared to Q2 2017).

  • Does this include all institutional owners?

    These rankings are based on a subset of tracked institutional investors who file SEC 13F reports. While not exhaustive, the dataset includes many of the largest and most influential funds.

  • Are these trades real-time?

    No. 13F filings are reported quarterly and may be delayed by up to 45 days. The data reflects positions at the end of the reporting period, not real-time trading activity.